Lion Street Advisors LLC Boosts Stake in American Healthcare REIT, Inc. $AHR

Lion Street Advisors LLC boosted its holdings in shares of American Healthcare REIT, Inc. (NYSE:AHR) by 6.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,373 shares of the company’s stock after purchasing an additional 430 shares during the quarter. Lion Street Advisors LLC’s holdings in American Healthcare REIT were worth $271,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of AHR. Wolff Wiese Magana LLC purchased a new position in shares of American Healthcare REIT during the 1st quarter valued at approximately $25,000. Physician Wealth Advisors Inc. purchased a new position in American Healthcare REIT during the second quarter valued at $34,000. Spirit of America Management Corp NY purchased a new position in American Healthcare REIT during the first quarter valued at $30,000. Avalon Trust Co purchased a new position in American Healthcare REIT during the first quarter valued at $36,000. Finally, Continuum Advisory LLC purchased a new position in American Healthcare REIT during the first quarter valued at $37,000. Hedge funds and other institutional investors own 16.68% of the company’s stock.

Insider Activity at American Healthcare REIT

In other news, EVP Mark E. Foster sold 3,850 shares of American Healthcare REIT stock in a transaction that occurred on Wednesday, September 3rd. The shares were sold at an average price of $41.89, for a total transaction of $161,276.50. Following the sale, the executive vice president owned 59,100 shares of the company’s stock, valued at approximately $2,475,699. The trade was a 6.12% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.00% of the company’s stock.

American Healthcare REIT Stock Up 1.8%

NYSE AHR opened at $41.28 on Tuesday. American Healthcare REIT, Inc. has a 52 week low of $24.21 and a 52 week high of $43.52. The company has a quick ratio of 0.48, a current ratio of 0.48 and a debt-to-equity ratio of 0.41. The business’s fifty day simple moving average is $41.72 and its 200-day simple moving average is $36.84. The firm has a market cap of $6.96 billion, a PE ratio of -187.63, a P/E/G ratio of 2.08 and a beta of 0.98.

American Healthcare REIT (NYSE:AHR) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.42 EPS for the quarter, topping the consensus estimate of $0.40 by $0.02. American Healthcare REIT had a negative return on equity of 1.43% and a negative net margin of 1.56%.The business had revenue of $542.50 million for the quarter, compared to analyst estimates of $539.49 million. During the same quarter in the previous year, the firm earned $0.33 EPS. The company’s quarterly revenue was up 7.5% compared to the same quarter last year. American Healthcare REIT has set its FY 2025 guidance at 1.640-1.680 EPS. As a group, equities analysts anticipate that American Healthcare REIT, Inc. will post 1.41 earnings per share for the current year.

American Healthcare REIT Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 17th. Stockholders of record on Tuesday, September 30th will be given a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 2.4%. The ex-dividend date of this dividend is Tuesday, September 30th. American Healthcare REIT’s payout ratio is presently -454.55%.

Analysts Set New Price Targets

A number of research analysts recently weighed in on AHR shares. UBS Group started coverage on shares of American Healthcare REIT in a research note on Friday, September 19th. They issued a “buy” rating and a $51.00 price target on the stock. Truist Financial raised their target price on American Healthcare REIT from $44.00 to $46.00 and gave the company a “buy” rating in a research report on Tuesday, August 26th. Robert W. Baird began coverage on American Healthcare REIT in a report on Friday, July 18th. They issued an “outperform” rating and a $41.00 price objective on the stock. Baird R W upgraded American Healthcare REIT to a “strong-buy” rating in a report on Thursday, July 17th. Finally, Scotiabank reissued an “outperform” rating on shares of American Healthcare REIT in a research note on Thursday, August 28th. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $44.11.

American Healthcare REIT Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.